SCHEMBL7230530

SCHEMBL7230530

O/N=C1/c2ccccc2CC1O

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
ACHE P22303 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HRH1 P35367 2/20 0.36
HRH4 Q9H3N8 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NOS3 P29474 3/20 0.34
NOS2 P35228 2/20 0.34
LMNA P02545 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TSHR P16473 1/20 0.34
HTR2A P28223 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8078753 1.00 HPGD (0.40) HPGDL3MBTL1ALDH1A1CYP1A2CYP2C19
SCHEMBL7230533 1.00 HPGD (0.40) HPGDL3MBTL1ALDH1A1CYP1A2CYP2C19
SCHEMBL354098 0.78 ACHE (0.53) HPGDL3MBTL1ALDH1A1CYP1A2CYP2C19
SCHEMBL29410363 0.78 ACHE (0.53) HPGDL3MBTL1ALDH1A1CYP1A2CYP2C19
SCHEMBL354099 0.78 ACHE (0.53) HPGDL3MBTL1ALDH1A1CYP1A2CYP2C19
SCHEMBL5970427 0.78 ACHE (0.53) HPGDL3MBTL1ALDH1A1CYP1A2CYP2C19
SCHEMBL3842551 0.74 METAP1 (0.41) HPGDL3MBTL1ALDH1A1CYP1A2CYP2C19
SCHEMBL31137726 0.74 SIGMAR1 (0.43) ACHENOS3NOS2HTR2A
SCHEMBL5263075 0.74 HRH1 (0.39) HPGDL3MBTL1ALDH1A1CYP1A2CYP2C19
SCHEMBL5263072 0.74 HRH1 (0.39) HPGDL3MBTL1ALDH1A1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6531617-B2 Adding an acid halide to a solution of aluminum chloride to form an alkylcarbonyloxy chromanone, which is further reacted with lithium (hydro)peroxide at a temperature of < 0 degrees C MERCK & CO., INC. 2003-03-11 US disclosed
US-20020095047-A1 Process for preparing hydroxychomanones and CIS-aminochromanols MERCK & CO., INC. 2002-07-18 US disclosed
US-6384244-B2 HYDROGENATING OXIME IN PRESENCE OF A CATALYST AND AN ACID; USEFUL AS CHEMICAL INTERMEDIATES IN PRODUCTION OF HIV PROTEASE INHIBITORS MERCK & CO., INC. 2002-05-07 US disclosed
US-20010056193-A1 Process for preparing cis- aminochromanols MERCK & CO., INC. 2001-12-27 US disclosed
WO-2001087873-A1 PROCESS FOR PREPARING CIS-AMINOCHROMANOLS MERCK & CO., INC. (US) 2001-11-22 WO disclosed
US-6057479-A MULTISTAGE REACTION OF HYDROXY INDANONE WITH AMINE TO FORM IMINE, HEATING AND HYDROGENATION NIPPON STEEL CHEMICAL CO., LTD. (JP) 2000-05-02 US disclosed
EP-0874059-A1 PROCESSES FOR PRODUCING INDANE DERIVATIVES NIPPON STEEL CHEMICAL CO., LTD. (JP) 1998-10-28 EP disclosed
EP-0874059-A2 PROCESSES FOR PRODUCING INDANE DERIVATIVES NIPPON STEEL CHEMICAL CO., LTD. (JP) 1998-10-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010056193-A1 Process for preparing cis- aminochromanols SRR, GRHPR, SPR HPGD 416/4885L3MBTL1 2906/4885ALDH1A1 2636/4885
US-20020095047-A1 Process for preparing hydroxychomanones and CIS-aminochromanols HACL2, HAAO, APEH HPGD 459/4885L3MBTL1 1983/4885ALDH1A1 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.